The Valley Desk

NCT05027074 · Interventional trial

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

Overall registry status Completed

Phase 2

Conditions End-Stage Kidney Disease, End-Stage Renal Disease, Kidney Failure, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov